Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00986583 · ClinicalTrials.gov registry record · NA
Effect of Succinylcholine on Patients Using Statins
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT00986583 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 70 participants.
The verdict
NCT00986583, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
Based on available mechanistic and clinical information, the investigators propose a nonrandomized study to evaluate the effect of succinylcholine in patients taking statins. The investigators' purpose is to evaluate the effect of succinylcholine on patients taking statins. Patients scheduled to undergo elective surgery (other then orthopedic, spinal, vascular or muscle) with planned endotracheal intubation will be approached regarding participation in the trial. Design of the study is complex because there is no way to randomize patients to statins or no statins and also no way to take them off the statins prior surgery. So statin use will not be randomized; confounding factors will be accounted for by stratification (every 10 years of age from 40-80 and gender) and statistical adjustment. The investigators propose to test the hypothesis that succinylcholine administration increases plasma myoglobin concentration more in patients who are on statins compared to patients who do not.
Interventions
- DRUG Succinylcholine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00986583
The ClinicalTrials.gov registry entry for NCT00986583 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Succinylcholine is the first listed.
NCT00986583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00986583 about?
NCT00986583 is a clinical study titled "Effect of Succinylcholine on Patients Using Statins". Based on available mechanistic and clinical information, the investigators propose a nonrandomized study to evaluate the effect of succinylcholine in patients taking statins. The investigators' purpose is to evaluate the effect of succinylcholine on patients taking statins. Patients scheduled to und...
What is the current status of trial NCT00986583?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2009-09. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00986583?
The interventions under investigation include: Succinylcholine (DRUG).
Who is sponsoring clinical trial NCT00986583?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.